A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
Clinical trial NCT03285178 · COMPLETED
Trial details
- NCT number
- NCT03285178
- Sponsor
- Cyclerion Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2020-07-22
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.